Abram's CoagCare System is a novel diagnostic platform for diagnosis and characterization of coagulation-related disorders, delivering rapid hemostasis information to improve clinical outcomes. The CoagCare system is designed as a point-of-care (POC) meter employing a single-use diagnostic test card. The platform utilizes proprietary technology for fast and highly accurate measurement of blood viscoelasticity and density, characterizing the entire blood coagulation cascade from blood clot formation to fibrinolysis in under 10 minutes, enabling the detection of blood clotting or bleeding disorders and guiding the use of therapy for optimal coagulation management.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
02/27/26	$11,750,000	Series A	Octapharma	undisclosed